Healthcare -
Biotechnology - NASDAQ - GB
$ 69.63
3.74 %
$ 737 M
Market Cap
-32.24
P/E
Price Target
Average
--32.09%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--34.02%
Net Income
Estimate
185.27%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Verona Pharma plc
Wall Street analysts predict an average 1-year price target for VRNA of $47.3 , with forecasts ranging from
a
low of
$36 to a high of $74 .
VRNA Lowest Price Target
Wall Street Target
36 USD
-48.30%
VRNA Average Price Target
Wall Street Target
47.3 USD
-32.09%
VRNA Highest Price Target
Wall Street Target
74 USD
6.28%
REVENUE FORECAST
Revenue Forecast Chart VRNA
EBIT FORECAST
EBIT Forecast Chart VRNA
NET INCOME FORECAST
Net Income Chart VRNA